SG11201504422XA - Transmucosal delivery of glatiramer acetate - Google Patents

Transmucosal delivery of glatiramer acetate

Info

Publication number
SG11201504422XA
SG11201504422XA SG11201504422XA SG11201504422XA SG11201504422XA SG 11201504422X A SG11201504422X A SG 11201504422XA SG 11201504422X A SG11201504422X A SG 11201504422XA SG 11201504422X A SG11201504422X A SG 11201504422XA SG 11201504422X A SG11201504422X A SG 11201504422XA
Authority
SG
Singapore
Prior art keywords
glatiramer acetate
transmucosal delivery
transmucosal
delivery
glatiramer
Prior art date
Application number
SG11201504422XA
Other languages
English (en)
Inventor
Ursula Geister
Stephan Schweizer
Martina Buerger
Ralph Stefan
Gerald Huber
Tanja Pries
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of SG11201504422XA publication Critical patent/SG11201504422XA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201504422XA 2012-12-21 2013-12-20 Transmucosal delivery of glatiramer acetate SG11201504422XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261745226P 2012-12-21 2012-12-21
PCT/US2013/077034 WO2014100639A1 (fr) 2012-12-21 2013-12-20 Administration transmucosale d'acétate de glatiramère

Publications (1)

Publication Number Publication Date
SG11201504422XA true SG11201504422XA (en) 2015-07-30

Family

ID=50979257

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201504422XA SG11201504422XA (en) 2012-12-21 2013-12-20 Transmucosal delivery of glatiramer acetate

Country Status (15)

Country Link
US (1) US20160193276A1 (fr)
EP (1) EP2934492A4 (fr)
JP (1) JP2016503803A (fr)
KR (1) KR20150111918A (fr)
CN (1) CN104869983A (fr)
AU (1) AU2013361053A1 (fr)
BR (1) BR112015014095A2 (fr)
CA (1) CA2895359A1 (fr)
EA (1) EA201591188A1 (fr)
HK (2) HK1214134A1 (fr)
IL (1) IL239280A0 (fr)
MX (1) MX2015007678A (fr)
SG (1) SG11201504422XA (fr)
WO (1) WO2014100639A1 (fr)
ZA (1) ZA201505049B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ609938A (en) 2010-10-11 2015-11-27 Teva Pharma Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate
US8815511B2 (en) 2011-10-10 2014-08-26 Teva Pharmaceutical Industries, Ltd. Determination of single nucleotide polymorphisms useful to predict response for glatiramer acetate
UY35790A (es) 2013-10-21 2015-05-29 Teva Pharma Marcadores genéticos que predicen la respuesta al acetato de glatiramer
EP3119413B1 (fr) 2014-03-17 2021-05-12 Mapi Pharma Limited Administration sublinguale d'acétate de glatiramère
CN106924175B (zh) * 2015-12-29 2020-07-03 深圳翰宇药业股份有限公司 一种治疗多发性硬化症的药物组合物
CN108601737A (zh) * 2016-02-12 2018-09-28 特华制药株式会社 干法制粒物和含有该干法制粒物的固态制剂及它的制造方法
EP3645029B1 (fr) 2017-06-26 2023-01-18 Institut Pasteur Traitements pour éliminer des réservoirs de vih et réduire la charge virale

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60120648D1 (de) * 2000-02-18 2006-07-27 Yeda Res & Dev Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung
ZA200206457B (en) * 2000-02-18 2003-08-13 Yeda Res & Dev Oral, nasal and pulmonary dosage formulations of copolymer 1.
MXPA04000209A (es) * 2001-07-10 2005-03-07 Teva Pharma Sistema de administracion para la administracion de droga de orden cero, bifasica de orden cero, ascendente o descendente.
CA2596664A1 (fr) * 2005-02-17 2006-08-24 Teva Pharmaceutical Industries Ltd. Therapie combinee avec de l'acetate de glatiramere et de rasagiline destinee au traitement de la sclerose en plaques
JP2009515956A (ja) * 2005-11-22 2009-04-16 テバ ファーマシューティカル インダストリーズ リミティド テルミサルタンの医薬組成物
WO2007074472A2 (fr) * 2005-12-27 2007-07-05 Jubilant Organosys Limited Composition pharmaceutique se dissolvant dans la bouche et son procede de preparation
CN102887900B (zh) * 2006-09-22 2015-04-29 药品循环公司 布鲁顿酪氨酸激酶的抑制剂
ES2329327B1 (es) * 2008-03-19 2010-09-17 Proyecto De Biomedicina Cima, S.L. Combinaciones sinergicas de 5'-metiltioadenosina.

Also Published As

Publication number Publication date
CN104869983A (zh) 2015-08-26
HK1214523A1 (zh) 2016-07-29
EP2934492A4 (fr) 2016-08-17
AU2013361053A1 (en) 2015-07-30
WO2014100639A1 (fr) 2014-06-26
JP2016503803A (ja) 2016-02-08
IL239280A0 (en) 2015-07-30
CA2895359A1 (fr) 2014-06-26
MX2015007678A (es) 2015-09-07
KR20150111918A (ko) 2015-10-06
US20160193276A1 (en) 2016-07-07
HK1214134A1 (zh) 2016-07-22
ZA201505049B (en) 2016-10-26
BR112015014095A2 (pt) 2017-07-11
EP2934492A1 (fr) 2015-10-28
EA201591188A1 (ru) 2016-04-29

Similar Documents

Publication Publication Date Title
HK1215817A1 (zh) 內容遞送框架
ZA201502352B (en) Liposomal drug delivery system
IL236268B (en) Preparations for mucosal administration and their uses
EP2683431A4 (fr) Système d'administration de médicament
HK1208155A1 (en) Transmucosal delivery of engineered polypeptides
EP2836982A4 (fr) Délivrance de contenu numérique
HK1214523A1 (zh) 醋酸格拉替雷的透粘膜給藥
HK1207295A1 (en) Transmucosal delivery of tocotrienol
HK1202826A1 (en) Medicament delivery devices
HK1215529A1 (zh) 口腔經粘膜藥物遞送系統
GB201213491D0 (en) Content delivery system
AU2013344654A1 (en) Oral transmucosal drug delivery system
HK1202827A1 (zh) 改進型藥物輸送裝置
IL229425B (en) Controlled release drug administration preparations
HK1214522A1 (zh) 醋酸格拉默的口腔透黏膜給藥
HK1215668A1 (zh) 醋酸卡泊芬淨製劑
SG10201609440WA (en) Multi-additive delivery system
EP2926712A4 (fr) Système d'insufflation
PL2908837T3 (pl) Kompozycje do dostarczania leku
SG11201405743QA (en) Liposomal delivery system
GB201121693D0 (en) Medicament delivery technology